Why the study?
Are there gender-related differences in acetazolamide-induced cerebral vasodilatory response in healthy subjects?
Are there gender-related differences in acetazolamide-induced cerebral vasodilatory response in healthy subjects?
Premenopausal women exhibit a significantly higher cerebral vasodilatory response to acetazolamide compared to age-matched men, a difference that disappears after menopause.
Sex differences in acetazolamide reactivity may support sex-specific norms; hypothesis-generating and should not yet change practice.
Cerebrovascular reactivity, cerebrovascular reserve capacity, and velocity acceleration can be easily and reliably assessed by measuring acetazolamide-induced changes using transcranial Doppler. The authors' aim was to determine whether there are gender-related differences in these parameters. Fifty-six healthy subjects (27 males, 29 females) were examined using transcranial Doppler. Velocities in the middle cerebral artery on both sides were recorded before and at 5, 10, 15, and 20 minutes after intravenous administration of 1 g acetazolamide. The baseline mean flow velocity in the middle cerebral artery was significantly higher in women than in men (p < 0.02). After acetazolamide administration, significantly higher cerebrovascular reactivity, cerebrovascular reserve capacity, and velocity acceleration were observed in females than in males (p < 0.001 in all cases). Subgroup analysis showed that women before menopause responded with higher cerebrovascular reserve capacity and velocity acceleration than age-matched men (p < 0.01 and p < 0.001, respectively), but no significant difference was found between females after menopause and men of similar age.
No takes yet. Share an insight, caveat, or question.
Oláh et al. (2000) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: